Accelerated product development, industrialisation and regulatory support
Concurrent engineering of various parties underpinned by digital solution platform
Support with collaboration and solution networking
Actively connecting innovators with each other as well as regulatory experts, project support engineers, manufacturing experts and clinicians
Support in securing demand and funding
Providing a platform to facilitate seamless and mutually beneficial relationships between product suppliers, buyers and funders
COVID-19 Problem Statement: Create medical solutions safely, effectively and lightning fast
“COVID-19 is bringing out the best of innovativeness in South Africans to design and produce something quickly to help. The challenge is that whatever gets developed must be safe, functional and cost-effective - while at the same time being available yesterday. This is only possible through concurrent engineering and linking up all the parties for seamless hand-overs and streamlined product development, industrialization, regulation, funding and demand activities. We have a wonderful opportunity to not only fast-track innovative product solutions for COVID-19, but also to create the basis for a reinvigorated and highly competitive medical device sector in the future.”
(COVID-19 Agile Solutions Team Coordinator)
Our objective is to support innovators to successfully develop, industrialize and obtain regulatory approval of their products for a real on-the-ground impact.
The result being products that...
Are well engineered and suited to the medical use environment;
Are documented and fulfil product design, engineering and manufacturing requirements;
Fulfil the regulatory requirements in terms of medical file standards as well as other regulations regarding manufacturing and distribution;
can be seamlessly transferred to various production and supply parties;
Fulfil the needs of the market resulting in firm orders;
Can be easily managed through their life-cycle
Can be financed through order commitments or other forms of funding.
By participating with the COVID-19 Agile solutions team and the Medical Device Regulatory Working Group (MDRWG), organisations will benefit in a variety of ways as outlined above and have the confidence that best-practice technologies are used to digitalize processes and optimize multi-party collaboration.
The use of agile product development and industrialization practices guarantees the necessary acceleration to market of highly scalable, regulatory compliant and cost-effective solutions, that meet the needs of the front-line fight against COVID-19.
Achieving this is ensured with the use of a state- of-the-art digital product life cycle management platform that facilitates an environment of concurrent engineering and data management. This platform allows teams of engineers, clinicians and regulatory experts to be able to work with the latest “version of the truth” of the product throughout its life cycle.
The platform also makes certain that a systematic approach is followed from design and development through to regulatory approval and industrialization. This systematic approach is vital to ensure that the product can be manufactured at high volume as well as function exactly as per the user’s need and that it does so safely and cost-effectively.
SUBMIT YOUR PROPOSAL
Do you have a product that you believe is required to help wage the war against the COVID-19 pandemic?
If so please click below to see the process to follow with a Project Proposal Form and follow the instructions given
Additional information on IDC Covid-19 essential supplies intervention